Skip to main content

Enteral Nutrition Supplemented with l-glutamine in Patients with Sepsis

  • Chapter
  • First Online:
Glutamine in Clinical Nutrition

Abstract

Objective: To evaluate the effect of enteral nutrition (EN) supplemented with L-glutamine in patients with sepsis. Methods: Thirty patients received EN. Fifteen patients received EN supplemented with glutamine (30 g; GLN group) for 2 d followed by EN supplemented with calcium caseinate (30 g, CAS group), also over 2 d. The other 15 patients received EN with calcium caseinate (30 g; CAS group) for 2 d followed by EN with glutamine (30 g; GLN group), also over 2 days. One washout day with only EN was provided between every 2-d period of EN plus supplementation to all patients. Blood samples were taken before and after supplementation. Results: There were no changes in glycolytic parameters in either group. Leukocytes decreased in the two groups (from 13 650 to 11 500 in the CAS group, p = 0.019; from 12.850 to 11.000 in the GLN group, p = 0.046). Lymphocytes increased in the GLN group (from 954 to 1916, p < 0.0001) and were more numerous after glutamine supplementation (from 1916 to 1085, p < 0.0001, GLN versus CAS). Glutathione plasma concentrations did not differ significantly between the groups. No significant changes were observed in the plasma glutamine and glutamate concentrations. Conclusions: The utilization of glutamine glutamine, despite being supplied enterally, increased the percentage of lymphocytes, indicating that the amino acid was not retained by the enterocytes. The finding of an increased percentage and total number of lymphocytes, indicates significant improvement of the immune system. Considering the observed benefits and the absence of adverse effects, enteral and parenteral diets enriched with L-glutamine or L-alanyl-glutamine are currently recommended for severe ICU patients in order to modulate the immune system.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Bastian L, Weimann A. Immunonutrition in patients after multiple trauma. Br J Nutr. 2002;87(suppl):S133–4.

    Article  CAS  PubMed  Google Scholar 

  2. Jiang Z, Jiang H, Fürst P. The impact of glutamine dipeptides on outcome of surgical patients: systematic review of randomized controlled trials from Europe and Asia. Clin Nutr Suppl. 2004;1(1):17–23.

    Article  CAS  Google Scholar 

  3. Fürst P, Alteheld B, Stehle P. Why should a single nutrient—glutamine—improve outcome? The remarkable story of glutamine dipeptides. Clin Nutr Suppl. 2004;1(1):3–15.

    Google Scholar 

  4. Hasenboehler E, Wiliams A, Leinhase I, Morgan SJ, Smith W, Moore EE, Stahel PF. Metabolic changes after polytrauma: an imperative for early nutritional support. World J Emerg Surg. 2006;1(29):1–7.

    Google Scholar 

  5. Weitzel LRB, Wischmeyer PE. Glutamine in critical illness: the time has come, the time is now. Crit Care Med. 2010;26(3):515–25.

    CAS  Google Scholar 

  6. Bongers T, Griffiths RD, McArdle A. Exogenous glutamine: the clinical evidence. Crit Care Med. 2007;35(suppl):S545–52.

    Article  CAS  PubMed  Google Scholar 

  7. Kuhn KS, Muscaritoli M, Wischmeyer P, Stehle P. Glutamine as indispensable nutrient in oncology: experimental and clinical evidence. Eur J Clin Nutr. 2010;49(4):197–210.

    Article  CAS  Google Scholar 

  8. Novak F, Heyland DK, Avenell A, Drover JW, Su X. Glutamine supplementation in serius illness: a systematic review of the evidence. Crit Care Med. 2002;30(9):2022–9.

    Article  CAS  PubMed  Google Scholar 

  9. Fuentes-Orozco C, Anaya-Prado R, González-Ojeda A, Arenas-Márquez H, Cabrera-Privaral C, Cervantes-Guevara G, Barrera-Zepeda L. L-alanyl-l-glutamine-supplemented parenteral nutrition improves infectious morbidity in secondary peritonitis. Clin Nutr. 2004;23(1):13–21.

    Article  CAS  PubMed  Google Scholar 

  10. Ziegler TR, Ogden LG, Singleton KD, Luo M, Fernandez-Estivariz C, Griffith DP, Galloway JR, Wischmeyer PE. Parenteral glutamine increases serum heat shock protein 70 in critically ill patients. Intensive Care Med. 2005;31(8):1079–86.

    Article  PubMed  Google Scholar 

  11. Abilés J, Moreno-Torres R, Moratalla G, Castaño J, Abúd RP, Mudarra A, Machado MJ, Planells E, De la Cruz AP. Efectos de la suplementación con glutamina sobre el sistema antioxidante y la peroxidación lipídica en pacientes críticos con nutrición parenteral. Nutr Hosp. 2008;23(4):332–9.

    PubMed  Google Scholar 

  12. Dechelotte P, Hasselmann M, Cynober L, Allaouchiche B, Coëffier M, Hecketsweiler B, et al. L-alanyl-L-glutamine dipeptide-supplemented total parenteral nutrition reduces infectious complications and glucose intolerance in critically ill patients: The French controlled, randomized, double-blind, multicenter study. Crit Care Med. 2006;34(3):598–604.

    Article  CAS  PubMed  Google Scholar 

  13. Bakalar B, Duska F, Pachl J, Fric M, Otahal M, Pazout J, Andel M. Parenterally administered dipeptide alanyl-glutamine prevents worsening of insulin sensitivity in multiple-trauma patients. Crit Care Med. 2006;34(2):381–6.

    Article  CAS  PubMed  Google Scholar 

  14. Cetinbas F, Yelken B, Gulbas Z. Role of glutamine administration on cellular immunity after total parenteral nutrition enriched with glutamine in patients with systemic inflammatory response syndrome. J Crit Care. 2010;25(4):661. e1–6.

    Article  PubMed  Google Scholar 

  15. Windle EM. Glutamine supplementation in critical illness: Evidence, recommendations, and implications for clinical practice in burn care. J Burn Care Res. 2006;27(6):764–72.

    Article  PubMed  Google Scholar 

  16. Mondello S, Italiano D, Giacobbe MS, Mondello P, Trimarchi G, Aloisi C, Bramanti P, Spina E. Glutamine-supplemented total parenteral nutrition improves immunological status in anorectic patients. Nutrition. 2010;26(6):677–81.

    Article  CAS  PubMed  Google Scholar 

  17. Conejero R, Bonet A, Grau T, Esteban A, Mesejo A, Montejo JC, López J, Acosta JA. Effect of a glutamine-enriched enteral diet on intestinal permeability and infectious morbidity at 28 days in critically Ill patients with systemic inflammatory response syndrome: a randomized, single-blind, prospective, multicenter study. Nutrition. 2002;18(9):716–21.

    Article  CAS  PubMed  Google Scholar 

  18. Houdijk APJ, Rijnsburger ER, Janse J, Wesdorp RI, Weiss JK, McCamish MA, Teerlink T, Meuwissen SG, Haarman HJ, Thijs LG, van Leeuwen PA. Radomised trial of glutamine-enriched enteral nutrition on infeccious morbity in patients with multiple trauma. Lancet. 1998;352:772–6.

    Article  CAS  PubMed  Google Scholar 

  19. Senkal M, Haaker R, Deska T, Hummel T, Steinfort C, Zumtobel V, Alteheld B, Stehle P. Early enteral gut feeding with conditionally indispensable pharmaconutrients in metabolically safe and is well tolerated in postoperative cancer patients—a pilot study. Clin Nutr. 2004;23(5):1193–8.

    Article  CAS  PubMed  Google Scholar 

  20. Cavalcante AAM, Campelo MWS, Vasconcelos MPP, Ferreira CM, Guimarães SB, Garcia JHP, Vasconcelos PRL. Enteral nutrition supplemented with L-glutamine in patients with systemic inflammatory response syndrome due to pulmonary infection. Nutrition. 2012;28(4):397–402.

    Article  CAS  PubMed  Google Scholar 

  21. Lim V, Korourian S, Todorova VK, Kaufmann Y, Klimberg VS. Glutamine prevents DMBA-induced squamous cell cancer. Oral Oncol. 2009;45(2):148–55.

    Article  CAS  PubMed  Google Scholar 

  22. Coëffier M, Tamion F, Déchelotte P. Supplémentation parentérale en glutamine en réanimation: preuves cliniques et mecanismes d’action. Réanimation. 2009;18(6):506–10.

    Article  Google Scholar 

  23. Newsholme P. Why is L-glutamine metabolism important to cells of the immune system in health, post injury, surgery or infection? J Nutr. 2001;131(suppl):2515S–22.

    CAS  PubMed  Google Scholar 

  24. Cruzat VF, Petry ER, Tirapegui J. Glutamina: Aspectos Bioquímicos, Metabólicos, Moleculares e Suplementação. Revista Brasileira de Medicina do Esporte. 2009;15(5):392–7.

    Article  Google Scholar 

  25. Biolo G, Zorat F, Antonione R, Ciocchi B. Muscle glutamine depletion in intensive care unit. Int J Biochem Cell Biol. 2005;37(10):2169–79.

    Article  CAS  PubMed  Google Scholar 

  26. Calder PC, Yaqoob P. Glutamine and the immune system. Amino Acids. 1999;17:227–41.

    Article  CAS  PubMed  Google Scholar 

  27. Newsholme EA, Calder PC. The proposed role of glutamine in some cells of the immune system and speculative consequences for the whole animal. Nutrition. 1997;13(718):728–30.

    Article  CAS  PubMed  Google Scholar 

  28. Moskovitz B, Katz Y, Singer P, Nativ O, Rosenberg B. Glutamine metabolism and utilization: relevance to major problems in health care. Pharmacol Res. 1994;30(1):61–71.

    Article  CAS  PubMed  Google Scholar 

  29. Wernerman J. Glutamine supplementation. Annals Intensive Care. 2011;1(25):1–6.

    Google Scholar 

  30. Griffiths RD, Allen KD, Andrews FJ, Jones C. Infection, multiple organ failure, and survival in the intensive care unit: Influence of glutamine-supplemented parenteral nutrition on acquired infection. Nutrition. 2002;18:546–52.

    Article  CAS  PubMed  Google Scholar 

  31. Arruda IS, Aguilar-Nascimento JE. Benefits of early enteral nutrition with glutamine and probiotics in brain injury patients. Clin Sci. 2004;106:287–92.

    Article  Google Scholar 

  32. Dupertius YM, Raguso CA, Pichard C. Basics in clinical nutrition: nutrients which influence immunity—clinical and experimental data. Eur e-J Clin Nutr Metabol. 2009;4(1):e7–9.

    Article  Google Scholar 

  33. Karinch AM, Pan M, Lin CM, Strange R, Souba WW. Glutamine metabolism in sepsis and infection. J Nutr. 2001;131(suppl):2535S–8.

    CAS  PubMed  Google Scholar 

  34. Wilmore DW, Shabert JK. Role of glutamine in immunologic responses. Nutrition. 1998;14:618–26.

    Article  CAS  PubMed  Google Scholar 

  35. Cynober L. Médiateurs de línflammation: contrôle par les nutriments azotes. Nutrition Clinique et Métabolisme. 2000;14(3):194–200.

    Article  CAS  Google Scholar 

  36. Singer P, Smadja P. Diètes immuno-enrichies en protéines. Nutrition Clinique et Métabolisme. 2010;24(2):45–51.

    Article  CAS  Google Scholar 

  37. Burrin DG, Stoll B, Jiang R, Chang X, Hartmann B, Holst JJ, Greeley Jr GH, Reeds PJ. Minimal enteral nutrient requirements for intestinal growth in neonatal piglets: how much is enough? Am J Clin Nutr. 2000;71(6):1603–10.

    CAS  PubMed  Google Scholar 

  38. Rosenfeldt F, Wilson M, Lee G, Kure C, Ou R, Braun L, Haan J. Oxidative stress in surgery in an ageing population: pathophysiology and therapy. Exp Gerontol. 2013;48:45–54.

    Article  CAS  PubMed  Google Scholar 

  39. Takeshi M, Kazufumi O, Ichirou K, Masamichi H, Yoshihiro K, Hisao O. Possible role of increased oxidant stress in multiple organ failure after systemic inflammatory response syndrome. Crit Care Med. 2003;31(4):1048–52.

    Article  Google Scholar 

  40. Fläring UB, Rooyackers OE, Wernerman J, Hammarqvist F. Glutamine attenuates post-traumatic glutathione depletion in human muscle. Clin Sci. 2003;104(3):275–82.

    Article  PubMed  Google Scholar 

  41. Perricone C, Carolis C, Perricone R. Glutathione: a key player in autoimmunity. Autoimmun Rev. 2009;8(8):697–701.

    Article  CAS  PubMed  Google Scholar 

  42. Bonet A, Grau T. La glutamina, un aminoácido casi indispensable en el enfermo crítico. Medicine Intensiva. 2007;31(7):402–6.

    Article  CAS  Google Scholar 

  43. Heyland DK, Dhaliwal R, Day AG, Muscedere J, Drover J, Suchner U, et al. Canadian critical care trials group. Reducing deaths due to oxidative stress (the REDOXS study): rationale and study design for a randomized trial of glutamine and antioxidant supplementation in critically-ill patients. Proc Nutr Soc. 2006;65(3):250–63.

    Article  CAS  PubMed  Google Scholar 

  44. Alves WF, Aguiar EE, Guimarães SB, Filho ARS, Pinheiro PMA, Soares DSD, Vasconcelos PRL. L-alanyl-glutamine preoperative infusion in patients with critical limb ischemia subjected to distal revascularization reduces tissue damage and protects from oxidative stress. Ann Vasc Surg. 2010;24(4):461–7.

    Article  PubMed  Google Scholar 

  45. Francis R, Michel H. Avec quoi nourrir l’intestin agressée? Nutrition Clinique et Métabolisme. 2000;14(4):341–9.

    Article  Google Scholar 

  46. Wiest R, Rath HC. Bacterial translocation in the gut. Best Pract Res Clin Gastroenterol. 2003;17(3):397–425.

    Article  PubMed  Google Scholar 

  47. Grimble RF. Nutritional modulation of immune function. Proc Nutr Soc. 2001;60(3):389–97.

    Article  CAS  PubMed  Google Scholar 

  48. Grimble RF. Basics in clinical nutrition: Immunonutrition—Nutrients which influence immunity: Effect and mechanism of action. Eur e-J Clin Nutr Metabol. 2009;4(1):e10–3.

    Article  Google Scholar 

  49. Hulsewé KWE, van der Hulst RWWJ, van Acker BAC, von Meyenfeldt MF, Soeters PB. Inflammation rather than nutritional depletion determines glutamine concentrations and intestinal permeability. Clin Nutr. 2004;23(5):1209–16.

    Article  PubMed  Google Scholar 

  50. Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Wijngaerden EV, Bobbaers H, Bouinllon R. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006;354:449–61.

    Article  PubMed  Google Scholar 

  51. Kumar S, Leaper DJ. Basic science of sepsis. Surgery. 2005;23(8):272–7.

    Google Scholar 

  52. Garcia-de-Lorenzo A, Zarazaga A, Garcia-Luna PP, Gonzalezhuix F, López-Martínez J, Miján A, Quecedo L, Casimiro C, Usán L, Lano J. Clinical evidence for enteral nutritional support with glutamine: a systematic review. Nutrition. 2003;19(9):805–11.

    Article  CAS  PubMed  Google Scholar 

  53. Galera SC, Fechine FV, Teixeira MJ, Coelho ZCB, Vasconcelos RC, Vasconcelos PRL. The safety of oral use of L-glutamine in middle-aged and elderly individuals. Nutrition. 2010;26(4):375–81.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ana Augusta Monteiro Cavalcante M.Sc., Ph.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Cavalcante, A.A.M., de Vasconcelos, P.R.L. (2015). Enteral Nutrition Supplemented with l-glutamine in Patients with Sepsis. In: Rajendram, R., Preedy, V., Patel, V. (eds) Glutamine in Clinical Nutrition. Nutrition and Health. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-1932-1_13

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-1932-1_13

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-1931-4

  • Online ISBN: 978-1-4939-1932-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics